TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in TScan Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +3 vs. Q3 2021
- Shares held
- 9.86M
- +972.5K (+10.9%) vs. Q3 2021
- Total value
- $44.4M
- −$29.8M (−40.1%) vs. Q3 2021
- New holders
- 10
- 2 more added
- Sold out
- 7
- 6 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 1,498,538 | $6.74M | 0.00% | −2,039−0.1% | Reduced |
| Baker Bros. Advisors LP | 1,425,000 | $6.41M | 0.03% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,282,976 | $5.77M | 0.09% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 1,255,317 | $5.65M | 0.10% | 00.0% | Unchanged |
| Deer Management Co. LLC | 1,245,505 | $5.61M | 0.14% | +1,245,505 | New |
| Alphabet Inc. | 1,077,080 | $4.85M | 0.12% | 00.0% | Unchanged |
| DC Funds, LP | 630,000 | $2.83M | 16.79% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 550,000 | $2.48M | 0.00% | +53,417+10.8% | Added |
| Vanguard Group Inc | 238,014 | $1.07M | 0.00% | −206,880−46.5% | Reduced |
| Tekla Capital Management LLC | 200,000 | $900.0K | 0.03% | 00.0% | Unchanged |
| Woodline Partners LP | 99,900 | $450.0K | 0.01% | +99,900 | New |
| Norges Bank | 60,000 | $270.0K | 0.00% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 48,600 | $219.0K | 0.06% | +48,600 | New |
| Bridgeway Capital Management, LLC | 40,000 | $180.0K | 0.00% | +40,000 | New |
| DC Investments Management, LLC | 35,563 | $160.0K | 0.23% | 00.0% | Unchanged |
| Morgan Stanley | 27,404 | $123.0K | 0.00% | −832−2.9% | Reduced |
| Caas Capital Management LP | 25,633 | $115.0K | 0.01% | −49,367−65.8% | Reduced |
| Geode Capital Management, LLC | 25,421 | $114.0K | 0.00% | +12,635+98.8% | Added |
| Marquette Asset Management, LLC | 21,618 | $97.0K | 0.02% | +21,618 | New |
| HRT Financial LP | 20,829 | $93.0K | 0.00% | +20,829 | New |
| LPL Financial LLC | 13,000 | $59.0K | 0.00% | +13,000 | New |
| Millennium Management LLC | 12,276 | $55.0K | 0.00% | −17,964−59.4% | Reduced |
| State Street Corp | 12,200 | $55.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 11,307 | $51.0K | 0.00% | +11,307 | New |
| Tower Research Capital LLC (TRC) | 3,770 | $17.0K | 0.00% | +3,770 | New |
| Royal Bank of Canada | 1,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 811 | $4.00K | 0.00% | −135−14.3% | Reduced |
| Bank of America Corp | 189 | $1.00K | 0.00% | +189 | New |
| Wells Fargo & Company | 41 | $0 | 0.00% | 00.0% | Unchanged |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −139,566−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −22,817−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −22,200−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −11,922−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −11,531−100.0% | Sold out |
| Deer IX & Co. Ltd. | – | – | – | – | Not filed |